Literature DB >> 26254497

Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs.

Jason Grebely1, Philip Bruggmann2, Carla Treloar3, Jude Byrne4, Tim Rhodes5, Gregory J Dore6.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26254497     DOI： 10.1016/j.drugpo.2015.07.007

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN： 0955-3959


× No keyword cloud information.
  15 in total

1.  Estimating HIV and HCV prevalence among people who inject drugs in 5 Ukrainian cities using stratification-based respondent driven and random sampling.

Authors:  Alexei Zelenev; Portia Shea; Alyona Mazhnaya; Anna Meteliuk; Iryna Pykalo; Ruthanne Marcus; Tatiana Fomenko; Tatiana Prokhorova; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2018-11-29

2.  Experiences Using Pre-Exposure Prophylaxis for Safer Conception Among HIV Serodiscordant Heterosexual Couples in the United States.

Authors:  Angela R Bazzi; Ashley A Leech; Dea L Biancarelli; Meg Sullivan; Mari-Lynn Drainoni
Journal:  AIDS Patient Care STDS       Date:  2017-07-18       Impact factor: 5.078

3.  Hepatitis C Cascade of Care Among Pregnant Women on Opioid Agonist Pharmacotherapy Attending a Comprehensive Prenatal Program.

Authors:  Kimberly Page; Lawrence Leeman; Steven Bishop; Sandra Cano; Ludmila N Bakhireva
Journal:  Matern Child Health J       Date:  2017-09

4.  Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine: An evaluation of programmatic and treatment outcomes.

Authors:  Alyona Mazhnaya; Anna Meteliuk; Tetiana Barnard; Alexei Zelenev; Sergii Filippovych; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2017-08-12

5.  Health care utilization and costs associated with direct-acting antivirals for patients with substance use disorders and chronic hepatitis C.

Authors:  Xinyi Jiang; Scott Martin Vouri; Vakaramoko Diaby; Weihsuan Lo-Ciganic; Robert Parker; Haesuk Park
Journal:  J Manag Care Spec Pharm       Date:  2021-10

6.  Exploring Patient Characteristics and Barriers to Hepatitis C Treatment in Patients on Opioid Substitution Treatment Attending a Community Based Fibro-scanning Clinic.

Authors:  Des Crowley; Walter Cullen; Eamon Laird; John S Lambert; Tina Mc Hugh; Carol Murphy; Marie Claire Van Hout
Journal:  J Transl Int Med       Date:  2017-06-30

7.  Should we treat acute hepatitis C? A decision and cost-effectiveness analysis.

Authors:  Emily D Bethea; Qiushi Chen; Chin Hur; Raymond T Chung; Jagpreet Chhatwal
Journal:  Hepatology       Date:  2018-01-24       Impact factor: 17.425

8.  The Impact of Direct-Acting Antiviral Therapy on End-Stage Liver Disease Among Individuals with Chronic Hepatitis C and Substance Use Disorders.

Authors:  Haesuk Park; Xinyi Jiang; Hyun Jin Song; Vincent Lo Re; Lindsey M Childs-Kean; Wei-Hsuan Lo-Ciganic; Robert L Cook; David R Nelson
Journal:  Hepatology       Date:  2021-07-01       Impact factor: 17.425

Review 9.  Global elimination of hepatitis C virus infection: Progresses and the remaining challenges.

Authors:  Reza Taherkhani; Fatemeh Farshadpour
Journal:  World J Hepatol       Date:  2017-11-28

10.  Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.

Authors:  Lucas Wiessing; Marica Ferri; Vendula Běláčková; Patrizia Carrieri; Samuel R Friedman; Cinta Folch; Kate Dolan; Brian Galvin; Peter Vickerman; Jeffrey V Lazarus; Viktor Mravčík; Mirjam Kretzschmar; Vana Sypsa; Ana Sarasa-Renedo; Anneli Uusküla; Dimitrios Paraskevis; Luis Mendão; Diana Rossi; Nadine van Gelder; Luke Mitcheson; Letizia Paoli; Cristina Diaz Gomez; Maitena Milhet; Nicoleta Dascalu; Jonathan Knight; Gordon Hay; Eleni Kalamara; Roland Simon; Catherine Comiskey; Carla Rossi; Paul Griffiths
Journal:  Harm Reduct J       Date:  2017-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.